AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31523063 — intervention group
Group type: COMPARATOR
Intervention: Standard removal of silicone stents (6 weeks postoperatively)
Number of subjects: 50
Study 31523063 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 50
Study 28965748 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist case finding and intervention program (Medication Therapy Management consultation, patient assessment, laboratory assessment, individualized CV risk assessment)
Number of subjects: 0
Study 28965748 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 26727706 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency microfocal vibratory stimulation (Equistasi)
Number of subjects: 0
Study 24603201 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined social and physical environmental intervention
Number of subjects: 412
Study 24603201 — intervention group
Group type: EXPERIMENTAL
Intervention: Social environmental intervention
Number of subjects: 412
Study 24603201 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical environmental intervention
Number of subjects: 412
Study 24603201 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 412
Study 22563215 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) 300 U/kg before CABG
Number of subjects: 71
Study 22563215 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline) before CABG
Number of subjects: 71
Study 19017764 — intervention group
Group type: COMPARATOR
Intervention: Bed rest (control group)
Number of subjects: 16
Study 19017764 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (exercise group)
Number of subjects: 16
Study 17376257 — intervention group
Group type: EXPERIMENTAL
Intervention: UC enhanced with psychiatrist-enhanced PEP
Number of subjects: 325
Study 17376257 — intervention group
Group type: EXPERIMENTAL
Intervention: UC enhanced with CBT-enhanced PEP
Number of subjects: 325
Study 17376257 — intervention group
Group type: COMPARATOR
Intervention: UC
Number of subjects: 325
Study 17376257 — intervention group
Group type: COMPARATOR
Intervention: PEP
Number of subjects: 325
Study 15142088 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with immediate implant and subepithelial connective tissue graft (test group)
Number of subjects: 116
Study 15142088 — intervention group
Group type: COMPARATOR
Intervention: Single immediate implants (control group)
Number of subjects: 116
Study 11446129 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (pharmacist intervention)
Number of subjects: 323
Study 11446129 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonintervention)
Number of subjects: 323
Study 9882085 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexketoprofen trometamol 25 mg tid
Number of subjects: 183
Study 9882085 — intervention group
Group type: COMPARATOR
Intervention: Ketoprofen 50 mg tid
Number of subjects: 183
Study 8049819 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg terbutaline
Number of subjects: 15
Study 8049819 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg terbutaline
Number of subjects: 15
Study 8049819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 2500111 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine (tricyclic antidepressant)
Number of subjects: 54
Study 2500111 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (5-HT reuptake inhibitor)
Number of subjects: 54
Study 2500111 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 54
Study 29992857 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 13885
Study 29992857 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 13885
Study 29992857 — intervention group
Group type: EXPERIMENTAL
Intervention: PAD with CAD
Number of subjects: 13885
Study 29992857 — intervention group
Group type: COMPARATOR
Intervention: PAD without CAD
Number of subjects: 13885
Study 26939522 — intervention group
Group type: EXPERIMENTAL
Intervention: Cer‐Mg and hydrocortisone
Number of subjects: 100
Study 26939522 — intervention group
Group type: EXPERIMENTAL
Intervention: Cer‐Mg and emollient
Number of subjects: 100
Study 26939522 — intervention group
Group type: COMPARATOR
Intervention: Cer‐Mg cream
Number of subjects: 100
Study 24957753 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep training program for children with ADHD, supervised by parents for 12 weeks.
Number of subjects: 40
Study 24957753 — intervention group
Group type: COMPARATOR
Intervention: Sleep hygiene information for children with ADHD (control group).
Number of subjects: 40
Study 24957753 — intervention group
Group type: COMPARATOR
Intervention: Sleep hygiene information for healthy children (control group).
Number of subjects: 40
Study 23136274 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic and treatment package for malaria and pneumonia using rapid diagnostic tests (RDT)
Number of subjects: 4216
Study 23136274 — intervention group
Group type: COMPARATOR
Intervention: Presumptive treatment with anti-malarial drugs; artemisinin combination therapy (ACT)
Number of subjects: 4216
Study 20498608 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized, multidisciplinary 12-week cardiac rehabilitation program
Number of subjects: 105
Study 20498608 — intervention group
Group type: COMPARATOR
Intervention: Control group (information session and follow-up care)
Number of subjects: 105
Study 18564952 — intervention group
Group type: EXPERIMENTAL
Intervention: Chiropractic management
Number of subjects: 30
Study 18564952 — intervention group
Group type: COMPARATOR
Intervention: Pain clinic management
Number of subjects: 30
Study 15766306 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg beta‐methyl‐6‐chloromelatonin
Number of subjects: 40
Study 15766306 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg beta‐methyl‐6‐chloromelatonin
Number of subjects: 40
Study 15766306 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg beta‐methyl‐6‐chloromelatonin
Number of subjects: 40
Study 15766306 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 12216010 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress Process Model
Number of subjects: 0
Study 10028205 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent in-hospital smoking cessation intervention
Number of subjects: 0
Study 9014675 — intervention group
Group type: EXPERIMENTAL
Intervention: TAPP repair
Number of subjects: 86
Study 9014675 — intervention group
Group type: COMPARATOR
Intervention: Shouldice technique
Number of subjects: 86
Study 9014675 — intervention group
Group type: COMPARATOR
Intervention: TPP repair
Number of subjects: 86
Study 9014675 — intervention group
Group type: EXPERIMENTAL
Intervention: TAPP and TPP repair
Number of subjects: 86
Study 1353678 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium (0.5 mg bolus i.v. followed by 0.5 mg infused over 30 min)
Number of subjects: 6
Study 1353678 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 6
Study 6381770 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise program (n = 72)
Number of subjects: 146
Study 6381770 — intervention group
Group type: COMPARATOR
Intervention: Usual care program (n = 74)
Number of subjects: 146
Study 29074070 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 0
Study 29074070 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Laryngoscopy (VL)
Number of subjects: 0
Study 29074070 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraglottic Airway Laryngopharyngeal Tube (SALT)
Number of subjects: 0
Study 29074070 — intervention group
Group type: COMPARATOR
Intervention: No PPE
Number of subjects: 0
Study 26420345 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen-coated transvaginal mesh
Number of subjects: 138
Study 26420345 — intervention group
Group type: COMPARATOR
Intervention: Conventional anterior colporrhaphy
Number of subjects: 138
Study 25407798 — intervention group
Group type: EXPERIMENTAL
Intervention: Aleglitazar 150 μg/day
Number of subjects: 302
Study 25407798 — intervention group
Group type: COMPARATOR
Intervention: Pioglitazone 45 mg/day
Number of subjects: 302
Study 22420349 — intervention group
Group type: EXPERIMENTAL
Intervention: Life review therapy
Number of subjects: 37
Study 22420349 — intervention group
Group type: COMPARATOR
Intervention: Placebo condition with supportive therapy
Number of subjects: 37
Study 20565430 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone ER (3-12 mg/day)
Number of subjects: 493
Study 17563512 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading of mandibular bar-retained overdenture supported by 4 endosseous implants loaded immediately after implant placement.
Number of subjects: 10
Study 17563512 — intervention group
Group type: COMPARATOR
Intervention: Delayed loading of mandibular bar-retained overdenture supported by 4 endosseous implants that remained submerged for a period of 4 months before loading.
Number of subjects: 10
Study 16159809 — intervention group
Group type: EXPERIMENTAL
Intervention: phVEGF-A165 (n=40)
Number of subjects: 80
Study 16159809 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=40)
Number of subjects: 80
Study 12182268 — intervention group
Group type: EXPERIMENTAL
Intervention: Cue exposure following a priming dose
Number of subjects: 0
Study 12182268 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral intervention
Number of subjects: 0
Study 10067908 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplements
Number of subjects: 21120
Study 10067908 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamins
Number of subjects: 21120
Study 10067908 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C supplements
Number of subjects: 21120
Study 7640921 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragmatic ultrasound (DUS)
Number of subjects: 30
Study 2182978 — intervention group
Group type: EXPERIMENTAL
Intervention: Active management with i.v. Ergometrine 0.5 mg
Number of subjects: 1429
Study 2182978 — intervention group
Group type: COMPARATOR
Intervention: Physiological management
Number of subjects: 1429
Study 2182978 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1429
Study 6797318 — intervention group
Group type: EXPERIMENTAL
Intervention: Subarachnoid block (SAB)
Number of subjects: 132
Study 6797318 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia (GA)
Number of subjects: 132
Study 31159750 — intervention group
Group type: COMPARATOR
Intervention: 3% saline with placebo
Number of subjects: 0
Study 31159750 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% saline with furosemide
Number of subjects: 0
Study 31159750 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% saline
Number of subjects: 0
Study 31159750 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide with 3% saline
Number of subjects: 0
Study 28626886 — intervention group
Group type: EXPERIMENTAL
Intervention: Incorporating activities to promote youth thriving into mentoring relationships
Number of subjects: 806
Study 28626886 — intervention group
Group type: COMPARATOR
Intervention: Standard services
Number of subjects: 806
Study 28626886 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive engagement with thriving promotion activities
Number of subjects: 806
Study 26012783 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook Group (social media delivery)
Number of subjects: 120
Study 26012783 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamphlet Group (standard delivery)
Number of subjects: 120
Study 26012783 — intervention group
Group type: COMPARATOR
Intervention: Control Group (usual care following Australian Dietary Guidelines)
Number of subjects: 120
Study 23718565 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (multifaceted implementation strategy including website access, newsletters, telephone approaches, outreach visits for physicians and managers; postgraduate course, training days, outreach visits, regional meetings, reporting system for occupational therapists)
Number of subjects: 45
Study 23718565 — intervention group
Group type: COMPARATOR
Intervention: Control group (no interventions for physicians and managers; postgraduate course for occupational therapists)
Number of subjects: 45
Study 23718565 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-participating physicians' referrals in experimental clusters
Number of subjects: 45
Study 22054619 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of primitive reflexes preoperatively
Number of subjects: 79
Study 22054619 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of two or more primitive reflexes postoperatively
Number of subjects: 79
Study 22054619 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of frontal release signs postoperatively
Number of subjects: 79
Study 22054619 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of three or more frontal release signs postoperatively
Number of subjects: 79
Study 19462695 — intervention group
Group type: EXPERIMENTAL
Intervention: Kansas City Cardiomyopathy Questionnaire (KCCQ)
Number of subjects: 83
Study 19462695 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Depression Scale (GDS)
Number of subjects: 83
Study 19462695 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini Mental State Examination
Number of subjects: 83
Study 17971616 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training for 8 weeks
Number of subjects: 64
Study 17971616 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aerobic training)
Number of subjects: 64
Study 15377842 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous clodronate (1500 mg each, seven cycles)
Number of subjects: 45
Study 15377842 — intervention group
Group type: COMPARATOR
Intervention: Control (no further therapy)
Number of subjects: 45
Study 11429351 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 1 mg/mL plus ketamine 1 mg/mL (Group MK)
Number of subjects: 71
Study 11429351 — intervention group
Group type: COMPARATOR
Intervention: Morphine 1 mg/mL (Group M)
Number of subjects: 71
Study 9701181 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine (375 mL/d)
Number of subjects: 6
Study 9701181 — intervention group
Group type: EXPERIMENTAL
Intervention: RWPP capsules (1 g/d)
Number of subjects: 6
Study 9701181 — intervention group
Group type: EXPERIMENTAL
Intervention: RWPPs in white wine (1 g/d)
Number of subjects: 6
Study 9701181 — intervention group
Group type: EXPERIMENTAL
Intervention: White wine (375 mL/d)
Number of subjects: 6
Study 9701181 — intervention group
Group type: COMPARATOR
Intervention: Control alcoholic drink (40 g ethanol/d)
Number of subjects: 6
Study 9701181 — intervention group
Group type: EXPERIMENTAL
Intervention: RWPPs (1 g/d)
Number of subjects: 6
Study 9701181 — intervention group
Group type: EXPERIMENTAL
Intervention: RWPPs (2 g/d)
Number of subjects: 6
Study 9701181 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (1000 IU/d)
Number of subjects: 6
Study 9390335 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacalcitol ointment (4 micrograms/g) once daily
Number of subjects: 287
Study 9390335 — intervention group
Group type: COMPARATOR
Intervention: Calcipotriol ointment (50 micrograms/g) twice daily
Number of subjects: 287
Study 1759492 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine (PT‐9K/129G, FHA, 69 kDa)
Number of subjects: 0
Study 1759492 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7117678 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabumetone (1 g at night) for 2 weeks
Number of subjects: 21
Study 7117678 — intervention group
Group type: COMPARATOR
Intervention: Naproxen (250 mg b.i.d) for 2 weeks
Number of subjects: 21
Study 7117678 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 21
Study 7117678 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician's assessment
Number of subjects: 21
Study 7117678 — intervention group
Group type: EXPERIMENTAL
Intervention: Side effects reported
Number of subjects: 21
Study 7117678 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug preference
Number of subjects: 21
Study 7117678 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal, hepatic or haematopoietic function
Number of subjects: 21
Study 31605520 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine chewing gum (CG)
Number of subjects: 14
Study 31605520 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine dissolvable mouth strips (CS)
Number of subjects: 14
Study 31605520 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine tablet (CT)
Number of subjects: 14
Study 31605520 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 14
Study 27507905 — intervention group
Group type: EXPERIMENTAL
Intervention: OC-Sensor (Eiken, Japan)
Number of subjects: 19291
Study 27507905 — intervention group
Group type: COMPARATOR
Intervention: FOB-Gold (Sentinel, Italy)
Number of subjects: 19291
Study 27507905 — intervention group
Group type: EXPERIMENTAL
Intervention: OC-Sensor
Number of subjects: 19291
Study 27507905 — intervention group
Group type: COMPARATOR
Intervention: FOB-Gold
Number of subjects: 19291
Study 27803090 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI Choice Decision Aid (DA)
Number of subjects: 124
Study 27803090 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 124
Study 25174846 — intervention group
Group type: COMPARATOR
Intervention: Traditional prosthesis group (n = 8)
Number of subjects: 16
Study 25174846 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomical prosthesis group (n = 8)
Number of subjects: 16
Study 21922186 — intervention group
Group type: EXPERIMENTAL
Intervention: FCR (Fludarabine, Cyclophosphamide, Rituximab)
Number of subjects: 184
Study 21922186 — intervention group
Group type: COMPARATOR
Intervention: PCR (Pentostatin, Cyclophosphamide, Rituximab)
Number of subjects: 184
Study 20570398 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in thickness of the banks of the inferior parietal lobule
Number of subjects: 54
Study 20570398 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in thickness of the gyrus and fundus of the inferior parietal lobule
Number of subjects: 54
Study 20570398 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological performance measures
Number of subjects: 54
Study 17968168 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training curriculum; 10 novice surgeons completed VR training followed by 3 porcine laparoscopic cholecystectomies each.
Number of subjects: 30
Study 17968168 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional training); 10 control subjects performed 5 cadaveric porcine laparoscopic cholecystectomies each.
Number of subjects: 30
Study 15868594 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung radiotherapy
Number of subjects: 46
Study 15868594 — intervention group
Group type: COMPARATOR
Intervention: Lung-only metastases
Number of subjects: 46
Study 15868594 — intervention group
Group type: COMPARATOR
Intervention: Unilateral disease or fewer than 5 metastatic lesions
Number of subjects: 46
Study 15868594 — intervention group
Group type: COMPARATOR
Intervention: Unfavorable histology
Number of subjects: 46
Study 15868594 — intervention group
Group type: COMPARATOR
Intervention: Age >10 years
Number of subjects: 46
Study 12522893 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan (150 mg once daily)
Number of subjects: 30
Study 12522893 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril (20 mg once daily)
Number of subjects: 30
Study 9552287 — intervention group
Group type: EXPERIMENTAL
Intervention: High noise exposure
Number of subjects: 33
Study 9552287 — intervention group
Group type: COMPARATOR
Intervention: Low noise exposure
Number of subjects: 33
Study 9552287 — intervention group
Group type: EXPERIMENTAL
Intervention: High effort
Number of subjects: 33
Study 9552287 — intervention group
Group type: EXPERIMENTAL
Intervention: Low effort
Number of subjects: 33
Study 8400769 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (once or 7 times a week)
Number of subjects: 40
Study 8400769 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (7 times a week)
Number of subjects: 40
Study 8400769 — intervention group
Group type: EXPERIMENTAL
Intervention: Active acupuncture
Number of subjects: 40
Study 8400769 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 40
Study 8400769 — intervention group
Group type: COMPARATOR
Intervention: Non-acupuncture
Number of subjects: 40
Study 8400769 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture at non-acupoints (ANA)
Number of subjects: 40
Study 3946804 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene 2 mg
Number of subjects: 6
Study 3946804 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene 1 mg
Number of subjects: 6
Study 3946804 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene 0.5 mg
Number of subjects: 6
Study 3946804 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 6
Study 30340505 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribociclib + letrozole
Number of subjects: 0
Study 30340505 — intervention group
Group type: COMPARATOR
Intervention: Placebo + letrozole
Number of subjects: 0
Study 27085566 — intervention group
Group type: EXPERIMENTAL
Intervention: Oximacro (36 mg PACs‐A) administered twice per day for 7 days
Number of subjects: 70
Study 27085566 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no PACs)
Number of subjects: 70
Study 27085566 — intervention group
Group type: EXPERIMENTAL
Intervention: Oximacro (36 mg PACs‐A)
Number of subjects: 70
Study 24399428 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline plus clonazepam (up to 3.0 mg/day)
Number of subjects: 181
Study 24399428 — intervention group
Group type: COMPARATOR
Intervention: Sertraline plus placebo
Number of subjects: 181
Study 24399428 — intervention group
Group type: COMPARATOR
Intervention: Venlafaxine (up to 225 mg/day)
Number of subjects: 181
Study 24399428 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall response rate (LSAS score <50)
Number of subjects: 181
Study 22516309 — intervention group
Group type: EXPERIMENTAL
Intervention: Four hygienic‐dietary recommendations
Number of subjects: 80
Study 22516309 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 80
Study 20167903 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV/STD risk-reduction intervention
Number of subjects: 1707